Vimarsana
Biggest News Aggregation in the World

Associate Scientist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Associate Scientist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Associate Scientist Today - Breaking & Trending Today

Quest Diagnostics: Lab Week 2024 - Deepika Kumar - Vimarsana News

Quest Diagnostics: Lab Week 2024 - Deepika Kumar

NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists.

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA - Vimarsana News

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

HOUSTON, April 04, 2024 -- FibroBiologics, Inc., , a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and potential cures for chronic...

Hippocratic AI Launches Nurse Advisory Council to Help - Vimarsana News

Hippocratic AI Launches Nurse Advisory Council to Help

Council launches with 10 distinguished nurses from leading health systems and digital health companies...

Hippocratic AI Launches Nurse Advisory Council to Guide AI in Healthcare - Vimarsana News

Hippocratic AI Launches Nurse Advisory Council to Guide AI in Healthcare

Hippocratic AI, a company developing a safety-focused Large Language Model (LLM) for healthcare launches its Nurse Advisory Council.

New gene therapy restores hearing in kids with hereditary deafness - Vimarsana News

New gene therapy restores hearing in kids with hereditary deafness

Researchers have developed a gene therapy that can help restore hearing function for children suffering from hereditary deafness.In the first human clinical trial that took place in December 2022, the team from Massachusetts Eye and Ear ...